We are live on ! Find out more
CVRS

CORINDUS VASCULAR ROBOTICS, INC
CVRS

Delisted

CVRS was delisted on the 28th of October, 2019.

40 hedge funds and large institutions have $104M invested in CORINDUS VASCULAR ROBOTICS, INC in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 6

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

48% more capital invested

Capital invested by funds: $70.2M → $104M (+$33.8M)

8% more funds holding

Funds holding: 3740 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
40
Holders Change
+3
Holders Change %
+8.11%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
19
Reduced
6
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HPM
1
HealthCor Partners Management
South Carolina
$35.7M
HM
2
HealthCor Management
New York
$28.6M
Wellington Management Group
3
Wellington Management Group
Massachusetts
$18.7M +$1.17M +1,010,676 +8%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$9.03M
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.77M +$132K +113,981 +6%
BFA
6
BlackRock Fund Advisors
California
$1.94M +$891K +768,738 +132%
CCP
7
Clough Capital Partners
Massachusetts
$1.57M -$1.19M -1,029,200 -48%
GH
8
GAM Holding
Switzerland
$1.52M +$66.3K +57,239 +6%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$504K +$40.6K +35,049 +11%
BIT
10
BlackRock Institutional Trust
California
$502K +$166K +143,544 +69%
Millennium Management
11
Millennium Management
New York
$497K -$170K -146,527 -30%
Northern Trust
12
Northern Trust
Illinois
$456K +$52.5K +45,304 +17%
State Street
13
State Street
Massachusetts
$369K +$32.9K +28,377 +12%
US Bancorp
14
US Bancorp
Minnesota
$287K
BIM
15
BlackRock Investment Management
Delaware
$255K +$116K +100,170 +129%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$235K +$58.7K +50,636 +44%
TCIM
17
TIAA CREF Investment Management
New York
$202K +$80.5K +69,491 +97%
California State Teachers Retirement System (CalSTRS)
18
California State Teachers Retirement System (CalSTRS)
California
$165K +$77.8K +67,091 +139%
Charles Schwab
19
Charles Schwab
California
$121K +$68.4K +59,000 +236%
TA
20
Teachers Advisors
New York
$84K +$28.6K +24,688 +72%
SG Americas Securities
21
SG Americas Securities
New York
$83K +$67.6K +58,294 New
SG
22
Societe Generale
$83K +$67.6K +58,294 New
Tudor Investment Corp
23
Tudor Investment Corp
Connecticut
$76K
AIG
24
American International Group
New York
$45.2K +$21.4K +18,459 +140%
NFA
25
Nationwide Fund Advisors
Ohio
$45K +$20.2K +17,455 +125%

CVRS Hedge Fund Activity: Q2 2016 in Review

40 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) for Q2 2016, worth a combined $104M — up 48% from $70.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CVRS positions and 5 closed out — a net gain of 3 holders — while 19 added to existing stakes and 6 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $1.17M. The largest seller was Clough Capital Partners, cutting an estimated $1.19M.

  • 40 institutional investors held CORINDUS VASCULAR ROBOTICS, INC (CVRS) as of Q2 2016, up from 37 in Q1 2016.
  • Funds reported $104M of CORINDUS VASCULAR ROBOTICS, INC stock for Q2 2016, up 48% quarter-over-quarter.
  • 8 funds opened new CORINDUS VASCULAR ROBOTICS, INC positions in Q2 2016 and 5 closed out, a net change of +3 holders.
  • The largest CORINDUS VASCULAR ROBOTICS, INC buyer in Q2 2016 was Wellington Management Group, an estimated $1.17M added.
  • The largest CORINDUS VASCULAR ROBOTICS, INC seller in Q2 2016 was Clough Capital Partners, an estimated $1.19M sold.

Based on aggregated 13F filings for Q2 2016.